Blood and platelets are scarce resources that are an essential part of the supportive care for paediatric cancer patients. There are many inherent risks involved with transfusions including acute transfusion reactions (ATRs). Following an initial ATR, prophylactic medications are commonly given prior to subsequent transfusions. However, there are risks with medication administration as well as negative implications for the health system. Our aim was to prevent the automatic prescribing of premedications prior to blood and platelet transfusions for ATRs. We hypothesised this would not increase the risk of harm.

中文翻译：

---

血制品输血的合理化术前用药实践：单中心质量倡议

血液和血小板是稀缺资源，是儿科癌症患者支持性护理的重要组成部分。输血涉及许多固有风险，包括急性输血反应 (ATR)。在最初的 ATR 之后，通常在随后的输血之前给予预防性药物。然而，药物管理存在风险以及对卫生系统的负面影响。我们的目标是防止在为 ATR 输血和血小板输注之前自动开出术前用药。我们假设这不会增加伤害的风险。